Papers

9

Total Citations

134

H-Index

7

About

Michael Poch is a urologic oncologist whose research centers on advancing minimally invasive surgical techniques for bladder, prostate, and penile cancers. His major contributions focus on robot-assisted radical cystectomy (RARC), where he has helped define short-term health-related quality of life outcomes and refined surgical control and margin status in high-risk cases. Poch’s work on intracorporeal diversion techniques, including tips and tricks for RARC, has been cited over 17 times, demonstrating its influence on surgical practice. He has also pioneered robotic inguinal lymphadenectomy for penile cancer, addressing the why, how, and what of this approach. With studies on body mass index’s impact on robotic conduit performance and urinary leak after partial nephrectomy, Poch has shaped perioperative care. His research on MRI radiomic pelvimetry to predict margin status after robotic prostatectomy showcases his integration of imaging and robotics. Collectively, his most-cited papers, with citations ranging from 5 to 28, underscore his role in improving outcomes through innovation in robotic urologic oncology.

Research Focus

Key Achievements

7
H-Index
9
Papers
134
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Short‐term patient reported health‐related quality of life ( <scp>HRQL</scp> ) outcomes after robot‐assisted radical cystectomy ( <scp>RARC</scp> )
28 citations · 2013
📈 Most Prolific Year: 2012 (2 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: Roswell Park Comprehensive Cancer Center, Moffitt Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago